相似文献
1
Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.
Eur J Cancer Clin Oncol. 1989 Apr;25(4):751-2. doi: 10.1016/0277-5379(89)90214-9.
2
Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
Eur J Cancer Clin Oncol. 1987 Nov;23(11):1707-8. doi: 10.1016/0277-5379(87)90454-8.
3
Phase II trial of menogaril in advanced colorectal cancer.
Invest New Drugs. 1988 Sep;6(3):227-30. doi: 10.1007/BF00175404.
4
Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
Invest New Drugs. 1991 Feb;9(1):77-8. doi: 10.1007/BF00194550.
5
Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
Eur J Cancer Clin Oncol. 1988 Feb;24(2):263-5. doi: 10.1016/0277-5379(88)90263-5.
6
Phase II study of intravenous menogaril in patients with advanced breast cancer.
J Natl Cancer Inst. 1988 Sep 7;80(13):1066-9. doi: 10.1093/jnci/80.13.1066.
7
Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
Cancer Treat Rep. 1986 Jun;70(6):721-5.
8
Phase I study of oral menogaril administered on a once weekly schedule.
Invest New Drugs. 1990 Feb;8(1):43-52. doi: 10.1007/BF00216923.
9
Phase I study of weekly intravenous administration of menogaril to adults with solid tumors.
Am J Clin Oncol. 1989 Dec;12(6):511-8. doi: 10.1097/00000421-198912000-00011.
10
Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy.
Am J Clin Oncol. 1988 Oct;11(5):524-7. doi: 10.1097/00000421-198810000-00003.
Zotero 插件